Elevated plasma visfatin levels correlate with poor prognosis of gastric cancer patients

Peptides

Volumn 58, Issue , 2014, Pages 60-64

  Lu, Guo Wen ^a   Wang, Qi Jun ^a   Xia, Min Ming ^a   Qian, Jiao ^a  

^a NINGBO UNIVERSITY   (China)

Author keywords

Biomarker; Gastric cancer; Prognosis; Visfatin

Indexed keywords

ANTINEOPLASTIC AGENT; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; CYTOKINE; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE, HUMAN; TUMOR MARKER;

ADULT; ARTICLE; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER PROGNOSIS; CANCER SIZE; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; DISTANT METASTASIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GASTRECTOMY; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MALE; OVERALL SURVIVAL; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; STOMACH CANCER; AGED; BLOOD; CLINICAL TRIAL; DISEASE FREE SURVIVAL; FOLLOW UP; MIDDLE AGED; MORTALITY; PREOPERATIVE PERIOD; STOMACH NEOPLASMS; SURVIVAL RATE;

ADULT; AGED; CYTOKINES; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; PREOPERATIVE PERIOD; STOMACH NEOPLASMS; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL;

EID: 84903585011     PISSN: 01969781     EISSN: 18735169     Source Type: Journal    
DOI: 10.1016/j.peptides.2014.05.016     Document Type: Article

References (30)

1. S.K. Bae, S.R. Kim, J.G. Kim, J.Y. Kim, T.H. Koo, and H.O. Jang et al. Hypoxic induction of human visfatin gene is directly mediated by hypoxia-inducible factor-1 FEBS Lett 580 2006 4105 4113 (Pubitemid 44037574)
2. T.Q. Bi, X.M. Che, X.H. Liao, D.J. Zhang, H.L. Long, and H.J. Li et al. Overexpression of Nampt in gastric cancer and chemopotentiating effects of the Nampt inhibitor FK866 in combination with fluorouracil Oncol Rep 26 2011 1251 1257
3. T.Q. Bi, and X.M. Che Nampt/PBEF/visfatin and cancer Cancer Biol Ther 10 2010 119 125
4. R.J. Bułdak, Ł. Bułdak, R. Polaniak, M. Kukla, E. Birkner, and R. Kubina et al. Visfatin affects redox adaptative responses and proliferation in Me45 human malignant melanoma cells: an in vitro study Oncol Rep 29 2013 771 778
5. J. Chen, J.F. Weng, W.C. Hong, L.F. Luo, W. Yu, and S.D. Luo Change in plasma visfatin level after severe traumatic brain injury Peptides 38 2012 8 12
6. M.S. Fazeli, H. Dashti, S. Akbarzadeh, M. Assadi, A. Aminian, and M.R. Keramati et al. Circulating levels of novel adipocytokines in patients with colorectal cancer Cytokine 62 2013 81 85
7. M.A. Folgueira, D.M. Carraro, H. Brentani, D.F. Patrão, E.M. Barbosa, and M.M. Netto et al. Gene expression profile associated with response to doxorubicin-based therapy in breast cancer Clin Cancer Res 11 2005 7434 7443 (Pubitemid 41507704)
8. A. Fukuhara, M. Matsuda, M. Nishizawa, K. Segawa, M. Tanaka, and K. Kishimoto et al. Visfatin: a protein secreted by visceral fat that mimics the effects of insulin Science 307 2005 426 430 (Pubitemid 40139988)
9. R. Gen, E. Akbay, N. Muslu, K. Sezer, and F. Cayan Plasma visfatin level in lean women with PCOS: relation to proinflammatory markers and insulin resistance Gynecol Endocrinol 25 2009 241 245
10. C.A. González, N. Sala, and T. Rokkas Gastric cancer: epidemiologic aspects Helicobacter 18 2013 34 38
11. C.P. Hsu, S. Oka, D. Shao, N. Hariharan, and J. Sadoshima Nicotinamide phosphoribosyltransferase regulates cell survival through NAD+ synthesis in cardiac myocytes Circ Res 105 2009 481 491
12. W. Hu, C.W. Liu, J. Su, J. Lu, Y. Zhu, and B.W. Liu Elevated plasma visfatin concentrations in patients with community-acquired pneumonia Peptides 43 2013 8 12
13. A. Jemal, F. Bray, M.M. Center, J. Ferlay, E. Ward, and D. Forman Global cancer statistics CA Cancer J Clin 61 2011 69 90
14. Kamangar F1, G.M. Dores, and W.F. Anderson Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world J Clin Oncol 24 2006 2137 2150 (Pubitemid 46655601)
15. X.Y. Li, S.H. Tang, X.C. Zhou, Y.H. Ye, X.Q. Xu, and R.Z. Li Preoperative serum visfatin levels and prognosis of breast cancer among Chinese women Peptides 51 2014 86 90
16. P. Liu, H. Li, J. Cepeda, Y. Xia, J.A. Kempf, and H. Ye et al. Regulation of inflammatory cytokine expression in pulmonary epithelial cells by pre-B-cell colony-enhancing factor via a nonenzymatic and AP-1-dependent mechanism J Biol Chem 284 2009 27344 27351
17. E. Maldi, C. Travelli, A. Caldarelli, N. Agazzone, S. Cintura, and U. Galli et al. Nicotinamide phosphoribosyltransferase (NAMPT) is over-expressed in melanoma lesions Pigm Cell Melanoma Res 26 2013 144 146
18. A.R. Moschen, R.R. Gerner, and H. Tilg Pre-B cell colony enhancing factor/Nampt/visfatin in in ammation and obesity-related disorders Curr Pharm Des 16 2010 1913 1920
19. T.E. Nakajima, Y. Yamada, T. Hamano, K. Furuta, T. Gotoda, and H. Katai et al. Adipocytokine levels in gastric cancer patients: resistin and visfatin as biomarkers of gastric cancer J Gastroenterol 44 2009 685 690
20. S. Ninomiya, M. Shimizu, K. Imai, K. Takai, M. Shiraki, and T. Hara et al. Possible role of visfatin in hepatoma progression and the effects of branched-chain amino acids on visfatin-induced proliferation in human hepatoma cells Cancer Prev Res (Phila) 4 2011 2092 2100
21. S. Ognjanovic, L.S. Tashima, and G.D. Bryant-Greenwood The effects of pre-B-cell colony-enhancing factor on the human fetal membranes by microarray analysis Am J Obstet Gynecol 189 2003 1187 1195 (Pubitemid 37373920)
22. P.S. Reddy, S. Umesh, B. Thota, A. Tandon, P. Pandey, and A.S. Hegde et al. PBEF1/NAmPRTase/Visfatin: a potential malignant astrocytoma/glioblastoma serum marker with prognostic value Cancer Biol Ther 7 2008 663 668
23. B. Samal, Y. Sun, G. Stearns, C. Xie, S. Suggs, and I. McNiece Cloning and characterization of the cDNA encoding a novel human pre-B-cell colony-enhancing factor Mol Cell Biol 14 1994 1431 1437
24. R.E. Shackelford, K. Mayhall, N.M. Maxwell, E. Kandil, and D. Coppola Nicotinamide phosphoribosyltransferase in malignancy: a review Genes Cancer 4 2013 447 456
25. W. Tian, Y. Zhu, Y. Wang, F. Teng, H. Zhang, and G. Liu et al. Visfatin, a potential biomarker and prognostic factor for endometrial cancer Gynecol Oncol 129 2013 505 512
26. B. Wang, M.K. Hasan, E. Alvarado, H. Yuan, H. Wu, and W.Y. Chen NAMPT overexpression in prostate cancer and its contribution to tumor cell survival and stress response Oncogene 30 2011 907 921
27. H. Yang, T. Yang, J.A. Baur, E. Perez, T. Matsui, and J.J. Carmona et al. Nutrient-sensitive mitochondrial NAD+ levels dictate cell survival Cell 130 2007 1095 1107 (Pubitemid 47410271)
28. Y. Yonemura, E. Bandou, T. Kawamura, Y. Endou, and T. Sasaki Quantitative prognostic indicators of peritoneal dissemination of gastric cancer Eur J Surg Oncol 32 2006 602 606 (Pubitemid 44063992)
29. T. Yu-Duan, W. Chao-Ping, C. Chih-Yu, L. Li-Wen, L. Tsun-Mei, and H. Chia-Chang et al. Elevated plasma level of visfatin/pre-b cell colony-enhancing factor in male oral squamous cell carcinoma patients Med Oral Patol Oral Cir Bucal 18 2013 e180 e186
30. L.Q. Zhang, D.P. Heruth, and S.Q. Ye Nicotinamide phosphoribosyltransferase in human diseases J Bioanal Biomed 3 2011 13 25